Spectrum Neuroscience and Treatment Institute — New York, New York

Spectrum Neuroscience and Treatment Institute is a clinical research site located in New York, New York, United States 10021-4157.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

Spectrum Neuroscience and Treatment Institute has participated in 6 clinical trials with 3 currently active.

Therapeutic areas: Treatment Resistant Depression, Generalized Anxiety Disorder, Autism Spectrum Disorder.

Sponsors: COMPASS Pathways, Definium Therapeutics US, Inc., BIXINK Therapeutics Co., Ltd..

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Spectrum Neuroscience and Treatment Institute?

Spectrum Neuroscience and Treatment Institute has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Spectrum Neuroscience and Treatment Institute conducted?

Spectrum Neuroscience and Treatment Institute has 6 clinical trials on record, with 3 currently active. Their work covers Treatment Resistant Depression, Generalized Anxiety Disorder, Autism Spectrum Disorder.

Is Spectrum Neuroscience and Treatment Institute accredited by Crixeo Health?

Yes — Spectrum Neuroscience and Treatment Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Spectrum Neuroscience and Treatment Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.